FDA Panel Rejects MDMA-Assisted Therapy For PTSD
An FDA advisory panel has recommended that the agency not approve the use of MDMA-assisted therapy as a treatment for PTSD.
Stay updated with breaking news from Shawn Hauser. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
An FDA advisory panel has recommended that the agency not approve the use of MDMA-assisted therapy as a treatment for PTSD.
DEA rules THCA not legal hemp, sparking industry concerns. Congress debates Farm Bill changes. Curaleaf criticizes amendment. Read now!
The historic shift would reclassify marijuana as a Schedule III drug, like Tylenol with codeine, ketamine and anabolic steroids.
The U.S. Drug Enforcement Administration (DEA) is reportedly moving cannabis from Schedule I to Schedule III
Stakeholders in the CBD industry are monitoring a DEA proposal concerning synthetic cannabinoids.